MAPK1 and central nervous system cancer: The group cutoff was selected as the median to divide the high expression group and the low expression group (cutoff-high = 50%; cutoff-low = 50%) for analyzing the mRNA expression of AKT1 and MAPK1 in glioma to verify their prognostic relationship.